Esgliteo

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Esgliteo, covering 2025-08-27 to 2025-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Esgliteo Post Marketing Surveillance (PMS) in Korean Patients With Type 2 Diabetes Mellitus